By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
The National Health Service pays for the operation known as sacral neuromodulation (NHS). It is used to assist in the treatment of patients with specific bowel and/or bladder disorders.
SNM is an implanted system (a medical device) that works by providing electrical signals to the nerves that regulate your bladder and pelvic floor to help enhance bladder function. The gadget can assist in regaining your bladder’s regular function; it resembles a pacemaker (used for the heart).
The gadget, which consists of a cable and a battery tucked away in your buttock, is implanted into the lower section of your spine or back. A basic or advanced evaluation (test phase) and a full system implant are the two steps of SNM (permanent implant).
The Global sacral neuromodulation system market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
The commercial debut of Axonics F15, a recharge-free implanted neurostimulator (INS) for the treatment of patients with bowel and bladder problems, took place in the US.
Primary cell battery type: INS .Size: 10 cm3Constant current automatically modifies the simulation output during stimulation. Full body MRI compatibility with whole-body 1.5T and 3.0T scanners
InterStim Micro neurostimulator for sacral neuromodulation (SNM) therapy available in the United States. Cleveland Clinic performed the first patient implant in the nation with the new device.
To enhance bladder and bowel control, sacral neuromodulation transmits electrical impulses to the sacral nerves in the lower back.
Unlike oral drugs that focus on the muscle aspect of bladder control, SNM provides symptom management through direct regulation of the nerve activity, restoring normal bladder-brain communication.
